+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2025-2030- Product Image
Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2025-2030- Product Image
Sale

Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904903
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoassay market is rapidly advancing, driven by technological innovation and increasing demand for precise diagnostic solutions across healthcare and research sectors. This report delivers an executive overview of the evolving landscape, equipping senior decision-makers with data-backed insights for strategic planning and action.

Market Snapshot: Immunoassay Market Growth and Opportunity

The Immunoassay Market grew from USD 28.29 billion in 2024 to USD 30.38 billion in 2025. It is expected to continue growing at a CAGR of 7.18%, reaching USD 42.90 billion by 2030. This consistent expansion highlights strong demand for robust diagnostic, monitoring, and research tools that leverage immunoassay technologies. Growth is fueled by adoption of high-sensitivity assays, automation, and digital integration, as well as increased focus on disease detection and patient-centered healthcare delivery.

Scope & Segmentation: Detailed Immunoassay Market Coverage

This report delivers thorough segmentation and in-depth analysis across all critical areas, including:

  • Type: Qualitative immunoassays, Quantitative immunoassays
  • Technology: Enzyme immunoassays, Enzyme-linked immunosorbent assays, Fluorescent immunoassays, Lateral flow assays, Radioimmunoassays, Western blot
  • Instruments: Analyzers & kits, Biosensors, Microfluidic devices, Microplates, PCR devices, Reagents (antibodies, antigens, blocking reagents, buffers & standards, enzymes, substrates), Software & services
  • Sample Types: Blood, saliva, tissue, urine
  • Detection Modes: Chemiluminescent, colorimetric, fluorometric, radioisotopic
  • Application Areas: Allergy, autoimmune diseases, cardiology, endocrinology, infectious diseases, oncology, toxicology (drug screening, environmental testing)
  • End Users: Contract research organizations, diagnostic laboratories, hospitals & clinics, pharmaceutical & biotechnology companies, research institutions
  • Deployment Types: Laboratory tests, Point-of-care tests
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (key markets such as United Kingdom, Germany, France, United Arab Emirates, South Africa), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Singapore)
  • Industry Players: Analysis includes companies such as Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and others

Key Takeaways: Strategic Insights for Senior Leaders

  • Next-generation immunoassays are increasing test throughput and accuracy, integrating microfluidics and digital data analytics to streamline laboratory and clinical operations.
  • Multiplex assays and portable, point-of-care solutions are redefining testing workflows, enabling rapid results with minimal sample volumes and broader clinical utility.
  • The adoption of artificial intelligence and machine learning within data analysis platforms improves biomarker discovery, supports clinical decision-making, and personalizes disease management strategies.
  • Strategic partnerships—linking assay developers, technology providers, and distributors—enable accelerated innovation and regional market access, especially in high-growth Asia-Pacific and EMEA territories.
  • Companies are focusing on resilient global procurement and supply strategies due to new regulatory pressures, prioritizing dual sourcing, localized production, and transparent customer communication.
  • Immunoassays play a vital role across specialties including oncology, infectious disease, and endocrinology, offering tailored solutions to diverse clinical and research requirements.

Tariff Impact: Navigating Supply Chain Complexity

New United States tariff measures introduced in 2025 have increased complexity in immunoassay supply chains and cost structures. Suppliers now contend with higher import duties, which can affect pricing, delivery timelines, and inventory planning. Many market players are responding by expanding domestic manufacturing and sourcing from tariff-exempt locations. Success in this environment depends on proactive procurement, collaborative supplier relationships, and clear communication strategies to maintain operational agility and customer trust.

Methodology & Data Sources

This research applies a multi-phase approach, starting with an extensive review of peer-reviewed literature, regulatory data, and industry white papers. Primary interviews with executives, R&D directors, and procurement specialists provided qualitative insights, triangulated with quantitative indicators for adoption rates and regional factors. Rigorous validation ensures all findings are actionable and reflect current market realities.

Why This Report Matters: Actionable Value for Industry Leaders

  • Empowers decision-makers with strategic recommendations to address technological, regulatory, and supply chain disruptions unique to the immunoassay landscape.
  • Delivers comprehensive segmentation and competitor analysis, informing resource allocation, partnership development, and product roadmap decisions.
  • Offers grounded opportunities to align innovation efforts with evolving market and patient needs, supporting sustainable growth and operational resilience.

Conclusion

The immunoassay market is shaped by rapid technological change and evolving clinical requirements. Forward-thinking strategies in innovation, supply chain management, and collaborative partnerships will position leaders for sustainable success in this dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid point-of-care immunoassays enabling decentralized COVID-19 and influenza testing with integrated digital readout platforms
5.2. Multiplexed microfluidic immunoassays driving high-throughput biomarker profiling in oncology and autoimmune disorder diagnostics
5.3. Nanoparticle-enhanced immunoassays boosting ultrasensitive detection of low-abundance serum biomarkers for early disease screening
5.4. Adoption of recombinant antibody fragments in immunoassays improving batch consistency and reducing cross-reactivity in clinical labs
5.5. Integration of artificial intelligence algorithms in immunoassay data analysis for real-time anomaly detection and reporting
5.6. Transition from analog to digital immunoassays leveraging single-molecule counting for enhanced quantitative precision in research settings
5.7. Development of lateral flow immunoassays with smartphone-based quantification for home monitoring of chronic disease biomarkers
5.8. Expansion of immunoassay-based companion diagnostics to guide targeted therapy selection in personalized oncology treatment regimens
5.9. Regulatory convergence and harmonization of immunoassay validation guidelines accelerating global product approvals and market entry timelines
5.10. Implementation of automated high-throughput immunoassay workstations to streamline serum and plasma sample processing in large clinical labs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoassay Market, by Type
8.1. Introduction
8.2. Qualitative Immunoassays
8.3. Quantitative Immunoassays
9. Immunoassay Market, by Technology
9.1. Introduction
9.2. Enzyme Immunoassays
9.3. Enzyme-Linked Immunosorbent Assay
9.4. Fluorescent Immunoassay
9.5. Lateral Flow Assay
9.6. Radioimmunoassay
9.7. Western Blot
10. Immunoassay Market, by Instruments
10.1. Introduction
10.2. Analyzers & Kits
10.3. Biosensors
10.4. Microfluidic Devices
10.5. Microplates
10.6. PCR Devices
10.7. Reagents
10.7.1. Antibodies
10.7.2. Antigens
10.7.3. Blocking Reagents
10.7.4. Buffers & Standards
10.7.5. Enzymes
10.7.6. Substrates
10.8. Software & Services
11. Immunoassay Market, by Sample Types
11.1. Introduction
11.2. Blood Samples
11.3. Saliva Samples
11.4. Tissue Samples
11.5. Urine Samples
12. Immunoassay Market, by Detection Modes
12.1. Introduction
12.2. Chemiluminescent
12.3. Colorimetric
12.4. Fluorometric
12.5. Radioisotopic
13. Immunoassay Market, by Application Areas
13.1. Introduction
13.2. Allergy
13.3. Autoimmune Diseases
13.4. Cardiology
13.5. Endocrinology
13.6. Infectious Diseases
13.7. Oncology
13.8. Toxicology
13.8.1. Drug Screening
13.8.2. Environmental Testing
14. Immunoassay Market, by End Users
14.1. Introduction
14.2. Contract Research Organizations
14.3. Diagnostic Laboratories
14.4. Hospitals & Clinics
14.5. Pharmaceutical & Biotechnology Companies
14.6. Research Institutions
15. Immunoassay Market, by Deployment Types
15.1. Introduction
15.2. Laboratory Tests
15.3. Point-of-care Test
16. Americas Immunoassay Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Immunoassay Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Immunoassay Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. Agilent Technologies Inc.
19.3.3. Almac Group Limited
19.3.4. ANP Technologies, Inc.
19.3.5. Autobio Diagnostics Co., Ltd.
19.3.6. Becton, Dickinson and Company
19.3.7. Bio-Rad Laboratories, Inc.
19.3.8. Bio-Techne Corporation
19.3.9. BioLegend, Inc.
19.3.10. bioMérieux S.A.
19.3.11. Biosurfit SA
19.3.12. Boditech Med Inc.
19.3.13. Charles River Laboratories International, Inc.
19.3.14. Danaher Corporation
19.3.15. Diasorin S.p.A.
19.3.16. Dynex Technologies, Inc.
19.3.17. Epitope Diagnostics Inc.
19.3.18. F. Hoffmann-La Roche Ltd.
19.3.19. Fapon Biotech Inc.
19.3.20. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
19.3.21. H.U. Group Holdings Inc.
19.3.22. J. Mitra & Co. Pvt. Ltd.
19.3.23. Kamiya Biomedical Company
19.3.24. Koninklijke Philips N.V.
19.3.25. Merck KGaA
19.3.26. MiCo BioMed, Inc.
19.3.27. NanoEntek
19.3.28. Nanomix, Inc.
19.3.29. OPKO Health, Inc.
19.3.30. Promega Corporation
19.3.31. QIAGEN N.V.
19.3.32. Quanterix Corporation
19.3.33. QuidelOrtho Corporation
19.3.34. Randox Laboratories Ltd.
19.3.35. Revvity, Inc. (Formarly PerkinElmer, Inc.)
19.3.36. Sekisui Diagnostics, LLC
19.3.37. Shenzhen Micropoint Biotechnologies Co., Ltd.
19.3.38. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
19.3.39. Siemens Healthineers AG
19.3.40. Sysmex Corporation
19.3.41. Tecan Trading AG
19.3.42. Thermo Fisher Scientific Inc.
19.3.43. Tosoh Corporation
19.3.44. WAK-Chemie Medical GmbH
19.3.45. Zoetis Inc.
19.3.46. Zybio Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2024 VS 2030 (%)
FIGURE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. IMMUNOASSAY MARKET: RESEARCHAI
FIGURE 32. IMMUNOASSAY MARKET: RESEARCHSTATISTICS
FIGURE 33. IMMUNOASSAY MARKET: RESEARCHCONTACTS
FIGURE 34. IMMUNOASSAY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. CANADA IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. CANADA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. CANADA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. CANADA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 170. CANADA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 171. CANADA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 172. CANADA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 173. CANADA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 174. CANADA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 175. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 176. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 177. CANADA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 178. CANADA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 179. CANADA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 180. CANADA IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 181. CANADA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 182. CANADA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 194. MEXICO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 195. MEXICO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 292. GERMANY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 293. GERMANY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 296. GERMANY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 297. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 298. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 299. GERMANY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 302. GERMANY IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 303. GERMANY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 305. FRANCE IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. FRANCE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 310. FRANCE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 312. FRANCE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 313. FRANCE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 314. FRANCE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 315. FRANCE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 316. FRANCE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 317. FRANCE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 318. FRANCE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 320. FRANCE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 321. FRANCE IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 322. FRANCE IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 323. FRANCE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 324. FRANCE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 345. ITALY IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 346. ITALY IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 347. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 348. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 349. ITALY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 350. ITALY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 351. ITALY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 352. ITALY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 353. ITALY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2024 (USD MILLION)
TABLE 354. ITALY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025-2030 (USD MILLION)
TABLE 355. ITALY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2024 (USD MILLION)
TABLE 356. ITALY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025-2030 (USD MILLION)
TABLE 357. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2024 (USD MILLION)
TABLE 358. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025-2030 (USD MILLION)
TABLE 359. ITALY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 360. ITALY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 361. ITALY IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 362. ITALY IMMUNOASSAY MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 363. ITALY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2024 (USD MILLION)
TABLE 364. ITALY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025-2030 (USD MILLION)
TABLE 365. SPAIN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 366. SPAIN IMMUNOASSAY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 367. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 368. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 369. SPAIN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Almac Group Limited
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Koninklijke Philips N.V.
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc. (Formarly PerkinElmer, Inc.)
  • Sekisui Diagnostics, LLC
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 30.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 42.9 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned46

Related Topics

Related Reports

Fluorescent Immunoassay Market by Product Type (Consumables, Instruments), Sample Type (Plasma, Serum, Urine), Deployment Types, Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Fluorescent Immunoassay Market by Product Type (Consumables, Instruments), Sample Type (Plasma, Serum, Urine), Deployment Types, Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Immunoassay Analyzers Market by Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Fluorescence Immunoassay), Product Type (Benchtop, Fully Automated, Semi-Automated), Application, End User, Throughput, Sample Type - Global Forecast 2025-2030 - Product Image

Immunoassay Analyzers Market by Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Fluorescence Immunoassay), Product Type (Benchtop, Fully Automated, Semi-Automated), Application, End User, Throughput, Sample Type - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 190 Pages
  • Global
From
Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030 - Product Image

Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Immunoassay Systems - Global Strategic Business Report - Product Image

Immunoassay Systems - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.